Proteon Therapeutics
Latest round
- Series D
Last raised
- May 2014
Total raised
- $116M
Investors
- 13
About Proteon Therapeutics
Proteon Therapeutics focuses on developing innovative therapies for unmet medical needs, particularly in the areas of cancer treatment and parenteral nutrition support.Proteon Therapeutics was founded in 2001 and is headquartered in Waltham, US. The company is dedicated to advancing therapies for conditions such as non-muscle invasive bladder cancer and choline deficiency.Proteon Therapeutics specializes in developing innovative therapies for unmet medical needs. Its primary products include TARA-002, an investigational cell therapy aimed at treating non-muscle invasive bladder cancer and lymphatic malformations, and IV Choline Chloride, which addresses choline deficiency in patients requiring parenteral support.14 mn.1 million to further develop its product pipeline and expand its market presence. The company aims to enhance its product offerings and explore new geographic markets by 2024.
Who invested in Proteon Therapeutics
13 investors across 6 rounds
See all investors in Proteon Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Proteon Therapeutics
Who invested in Proteon Therapeutics?
Proteon Therapeutics has 13 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Proteon Therapeutics raised?
Proteon Therapeutics has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Proteon Therapeutics last raise money?
Proteon Therapeutics's most recent round on record is a Series D, in May 2014.
What does Proteon Therapeutics do?
Proteon Therapeutics focuses on developing innovative therapies for unmet medical needs, particularly in the areas of cancer treatment and parenteral nutrition support.
Where is Proteon Therapeutics headquartered?
Proteon Therapeutics is headquartered in Waltham, US.
Which VCs invest in companies like Proteon Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Proteon Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Proteon Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.